Trial Profile
An Open-label Pilot Trial to Assess the Effect of Tegaserod on Improvement of Gastric Emptying in Patients With Diabetic Gastroparesis and Upper Gastrointestinal Symptoms
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2012
Price :
$35
*
At a glance
- Drugs Tegaserod (Primary)
- Indications Diabetic gastroparesis
- Focus Therapeutic Use
- Sponsors Novartis
- 10 May 2012 New trial record